The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation
- PMID: 10378692
- DOI: 10.1038/sj.onc.1202750
The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation
Abstract
A large body of evidence has been accumulated that demonstrates dominant effects of Myc proto-oncoproteins on different aspects of cellular growth. Myc is one of the few proteins that is sufficient to drive resting cells into the cell cycle and promote DNA synthesis. In line with this finding is that the constitutive expression of Myc in cells blocks their differentiation. These growth stimulating properties are most likely responsible for Myc's ability to initiate and promote tumor formation. Interestingly Myc can also sensitize cells to apoptosis, suggesting that this protein is part of a life-and-death switch. Molecularly Myc functions as a transcriptional regulator that needs to heterodimerize with Max to exert the biological activities described above and to regulate gene transcription. Myc and Max are just two members of a growing family of proteins referred to as the Myc/Max/Mad network. A hallmark of these proteins is that they possess a C-terminal basic region/helix-loop-helix/leucine zipper domain (bHLHZip). The bHLHZip domain specifies dimerization within the network and determines sequence specific DNA binding. Importantly this domain together with the N-terminal transactivation domain is essential for Myc biology. Here we have summarized the structural, functional, and regulatory aspects of the bHLHZip domain of Myc proteins.
Similar articles
-
Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.Oncogene. 1998 Mar 5;16(9):1149-59. doi: 10.1038/sj.onc.1201634. Oncogene. 1998. PMID: 9528857
-
Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.J Mol Biol. 1995 May 5;248(3):541-50. doi: 10.1006/jmbi.1995.0241. J Mol Biol. 1995. PMID: 7752223
-
Design and properties of a Myc derivative that efficiently homodimerizes.Oncogene. 1998 Nov 12;17(19):2463-72. doi: 10.1038/sj.onc.1202199. Oncogene. 1998. PMID: 9824157
-
New Myc-interacting proteins: a second Myc network emerges.Oncogene. 1999 May 13;18(19):2942-54. doi: 10.1038/sj.onc.1202725. Oncogene. 1999. PMID: 10378691 Review.
-
Functions of myc:max in the control of cell proliferation and tumorigenesis.Int Rev Cytol. 2004;238:183-226. doi: 10.1016/S0074-7696(04)38004-6. Int Rev Cytol. 2004. PMID: 15364199 Review.
Cited by
-
Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability.J Biol Chem. 2012 May 11;287(20):16199-208. doi: 10.1074/jbc.M111.335216. Epub 2012 Mar 27. J Biol Chem. 2012. PMID: 22453922 Free PMC article.
-
Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1.Biochem J. 2001 Sep 15;358(Pt 3):705-15. doi: 10.1042/0264-6021:3580705. Biochem J. 2001. PMID: 11535131 Free PMC article.
-
Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.J Am Chem Soc. 2009 Jun 10;131(22):7839-48. doi: 10.1021/ja901306q. J Am Chem Soc. 2009. PMID: 19449889 Free PMC article.
-
Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme.Front Oncol. 2013 Jul 11;3:182. doi: 10.3389/fonc.2013.00182. eCollection 2013. Front Oncol. 2013. PMID: 23875172 Free PMC article.
-
Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase.J Mammary Gland Biol Neoplasia. 2001 Jan;6(1):141-50. doi: 10.1023/a:1009528918064. J Mammary Gland Biol Neoplasia. 2001. PMID: 11467449 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources